EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Via Sasso 36
City: Urbino
State: marche
Zip: 61029
Country: IT
EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2018 | Series B | 3 | $32.4M |
Genextra Innogest Capital Sofinnova Partners Genextra Innogest Capital Sofinnova Partners |
12/2008 | Series A | 2 | $3.2M |
FM Management Innogest Capital FM Management Innogest Capital |
4/2018 | Unattributed | $32.4M |
Sofinnova Partners SAS Genextra S.p.A. Innogest Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|